Inogen, Inc. (NASDAQ:INGN) Q3 2020 Earnings Conference Call November 4, 2020 4:30 PM ET Company Participants Matthew Pigeon - IR Scott Wilkinson - President and CEO Alison Bauerlein - CFO Conference Call Participants Danielle Antalffy - SVB Leerink Matthew Mishan - KeyBanc Mike Matson - Needham & Company Margaret Kaczor - William Blair Operator Greetings and welcome to the Inogen’s Third Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 ( State or other jurisdiction ...

Company Overview August 2020 Notice regarding forward-looking statements 2 These slides and the accompanying oral presentation (the "Presentation") include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectations, estimates and projections based on information currently available to management. These forward-looking statements include, among others, statements relating to our expectations regarding changing reimbursement r ...

Inogen Inc (NASDAQ:INGN) Q2 2020 Results Conference Call August 3, 2020 4:30 PM ET Company Participants Matthew Basco - Investor Relations Scott Wilkinson - President and Chief Executive Officer Alison Bauerlein - Chief Financial Officer Conference Call Participants Danielle Antalffy - SVB Leerink Matthew Mishan - KeyBanc Michael Matson - Needham & Company Margaret Kaczor - William Blair Operator Greetings and welcome to the Inogen’s Second Quarter 2020 Financial Results Conference Call. At this time, all p ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 ( State or other jurisdiction of incorporation or organization) 326 Bollay Drive Goleta, CA 93117 (Address of principal exec ...

Company Overview May 2020 Notice regarding forward-looking statements 2 These slides and the accompanying oral presentation (the "Presentation") include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectations, estimates and projections based on information currently available to management. These forward-looking statements include, among others, statements relating to our expectations regarding changing reimbursement rate ...

Inogen, Inc. (NASDAQ:INGN) Q1 2020 Results Conference Call May 5, 2020 4:30 PM ET Company Participants Matt Bacso - IR Scott Wilkinson - CEO Ali Bauerlein - CFO Conference Call Participants Margaret Kaczor - William Blair Robbie Marcus - J.P. Morgan Matt Mishan - KeyBanc Mike Matson - Needham & Company Danielle Antalffy - SVB Leerink Operator Greetings and welcome to the Inogen First Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 ( State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) | Delaware | 33-0989359 | | --- | --- | | State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 ( State or other jurisdiction ...